- Home
- SWZ
as of 03-20-2026 2:39pm EST
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 76.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 68.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $5.84 - $9.43 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered SWZ Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Swiss Helvetia Fund Inc. (The) (SWZ)
Secretary
Avg Cost/Share
$5.98
Shares
10,000
Total Value
$59,800.00
Owned After
113,234
SEC Form 4
President and CEO
Avg Cost/Share
$5.97
Shares
12,500
Total Value
$74,625.00
Owned After
62,095
SEC Form 4
President and CEO
Avg Cost/Share
$6.01
Shares
12,000
Total Value
$72,120.00
Owned After
62,095
SEC Form 4
Secretary
Avg Cost/Share
$5.99
Shares
10,000
Total Value
$59,900.00
Owned After
113,234
SEC Form 4
Secretary
Avg Cost/Share
$6.01
Shares
5,000
Total Value
$30,050.00
Owned After
113,234
SEC Form 4
President and CEO
Avg Cost/Share
$6.05
Shares
14,918
Total Value
$89,762.10
Owned After
62,095
President and CEO
Avg Cost/Share
$6.20
Shares
2,000
Total Value
$12,400.00
Owned After
62,095
SEC Form 4
President and CEO
Avg Cost/Share
$6.17
Shares
5,000
Total Value
$30,850.00
Owned After
62,095
SEC Form 4
President and CEO
Avg Cost/Share
$6.15
Shares
1,674
Total Value
$10,318.80
Owned After
62,095
President and CEO
Avg Cost/Share
$6.14
Shares
4,000
Total Value
$24,540.00
Owned After
62,095
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| GOLDSTEIN PHILLIP | SWZ | Secretary | Mar 18, 2026 | Buy | $5.98 | 10,000 | $59,800.00 | 113,234 | |
| Dakos Andrew | SWZ | President and CEO | Mar 6, 2026 | Buy | $5.97 | 12,500 | $74,625.00 | 62,095 | |
| Dakos Andrew | SWZ | President and CEO | Mar 5, 2026 | Buy | $6.01 | 12,000 | $72,120.00 | 62,095 | |
| GOLDSTEIN PHILLIP | SWZ | Secretary | Mar 5, 2026 | Buy | $5.99 | 10,000 | $59,900.00 | 113,234 | |
| GOLDSTEIN PHILLIP | SWZ | Secretary | Mar 3, 2026 | Buy | $6.01 | 5,000 | $30,050.00 | 113,234 | |
| Dakos Andrew | SWZ | President and CEO | Mar 2, 2026 | Buy | $6.05 | 14,918 | $89,762.10 | 62,095 | |
| Dakos Andrew | SWZ | President and CEO | Feb 27, 2026 | Buy | $6.20 | 2,000 | $12,400.00 | 62,095 | |
| Dakos Andrew | SWZ | President and CEO | Feb 26, 2026 | Buy | $6.17 | 5,000 | $30,850.00 | 62,095 | |
| Dakos Andrew | SWZ | President and CEO | Feb 24, 2026 | Buy | $6.15 | 1,674 | $10,318.80 | 62,095 | |
| Dakos Andrew | SWZ | President and CEO | Feb 23, 2026 | Buy | $6.14 | 4,000 | $24,540.00 | 62,095 |
Compare SWZ vs Leading Stocks
See how SWZ stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SWZ Swiss Helvetia Fund Inc. (The) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.